Serum hsCRP and visfatin are elevated and correlate to carotid arterial stiffness in spinal cord-injured subjects

Study design: Cross-sectional comparison, control group. Objectives: To investigate the relationship between carotid arterial stiffness and circulating markers for cardiovascular disease (CVD) in spinal cord-injured (SCI) subjects compared with able-bodied (AB) individuals. Setting: University Resea...

Full description

Saved in:
Bibliographic Details
Published inSpinal cord Vol. 49; no. 9; pp. 961 - 966
Main Authors La Favor, J D, Hollis, B C, Mokshagundam, S L, Olive, J L
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.09.2011
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Study design: Cross-sectional comparison, control group. Objectives: To investigate the relationship between carotid arterial stiffness and circulating markers for cardiovascular disease (CVD) in spinal cord-injured (SCI) subjects compared with able-bodied (AB) individuals. Setting: University Research Laboratory, University of Louisville. Methods: SCI ( n =14) and AB ( n =13) subjects between 20–52 years of age were recruited to participate in the study. B-mode Doppler ultrasound was used to obtain carotid artery diameter measurements. Arterial stiffness was assessed via the stiffness index and distensibility coefficient. Markers of CVD risk were obtained by fasting blood draw. Results: Carotid arterial stiffness index ( P =0.061) and distensibility coefficient ( P =0.370) were not different between the SCI and AB groups. The SCI group had higher high-sensitivity C-reactive protein (hsCRP) ( P =0.046), triglycerides ( P =0.017), leptin ( P =0.040) and visfatin ( P <0.001) compared with the control group. Visfatin ( r =0.559, P =0.047), hsCRP ( r =0.633, P =0.037), insulin ( r =0.637, P =0.019) and HOMA ( r =0.614, P =0.026) significantly correlated with carotid arterial stiffness index in the SCI group. Conclusion: This study demonstrated that SCI subjects are at a high cardiovascular risk as indicated by elevated hsCRP levels. Elevations in hsCRP and visfatin may contribute to accelerated atherogenic processes in the SCI population.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:1362-4393
1476-5624
1476-5624
DOI:10.1038/sc.2011.56